Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (200)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
40
2025
3050
2.830
Why?
High-Throughput Nucleotide Sequencing
7
2022
179
1.130
Why?
Genomics
10
2023
270
0.850
Why?
Mutation
14
2022
1344
0.830
Why?
Software
4
2021
280
0.820
Why?
Plasma Cells
7
2025
239
0.750
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
125
0.640
Why?
Tumor Microenvironment
4
2024
255
0.590
Why?
Clonal Evolution
4
2020
59
0.560
Why?
Computational Biology
4
2020
211
0.530
Why?
Gene Expression Regulation, Neoplastic
6
2024
857
0.510
Why?
Algorithms
4
2020
668
0.480
Why?
Neoplasm Recurrence, Local
5
2024
643
0.450
Why?
Humans
48
2025
52593
0.400
Why?
Prognosis
13
2025
2118
0.400
Why?
Translocation, Genetic
7
2022
265
0.390
Why?
Neoplasms
2
2020
1308
0.380
Why?
Gene Expression Profiling
10
2025
1110
0.380
Why?
Positron-Emission Tomography
3
2025
303
0.380
Why?
Osteolysis
2
2022
75
0.370
Why?
Models, Molecular
1
2013
352
0.370
Why?
Hematopoietic Stem Cell Transplantation
3
2024
606
0.370
Why?
Diffusion Magnetic Resonance Imaging
2
2025
133
0.370
Why?
Chromosome Aberrations
3
2023
297
0.350
Why?
Genome, Human
3
2021
121
0.340
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Osteocytes
2
2024
226
0.340
Why?
Signal Transduction
4
2024
1714
0.330
Why?
Proteins
1
2013
354
0.330
Why?
Bone Marrow
3
2020
363
0.310
Why?
Epigenomics
2
2021
75
0.300
Why?
Disease Progression
8
2025
873
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1031
0.260
Why?
RANK Ligand
2
2024
187
0.250
Why?
Gene Rearrangement
2
2023
76
0.230
Why?
Oncogenes
3
2021
60
0.230
Why?
Chemokine CCL3
1
2024
13
0.230
Why?
HMGB1 Protein
1
2024
21
0.230
Why?
Chemokine CXCL12
1
2024
34
0.220
Why?
Bone Resorption
2
2024
302
0.210
Why?
Burkitt Lymphoma
1
2023
27
0.200
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
12
0.200
Why?
Gene Dosage
2
2020
78
0.200
Why?
Neoplasm, Residual
2
2025
173
0.200
Why?
Epigenesis, Genetic
3
2023
407
0.190
Why?
Proto-Oncogene Proteins c-akt
1
2023
172
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.190
Why?
Drug Resistance, Neoplasm
1
2024
327
0.190
Why?
Neoplasm Proteins
2
2021
328
0.190
Why?
Cell Communication
1
2022
72
0.180
Why?
Mice
8
2024
5958
0.180
Why?
Telomere Homeostasis
1
2021
11
0.180
Why?
Polycomb Repressive Complex 2
1
2021
48
0.180
Why?
Ubiquitination
1
2021
57
0.180
Why?
Transcriptome
3
2025
368
0.180
Why?
Chromosome Deletion
2
2023
141
0.180
Why?
Loss of Heterozygosity
2
2018
78
0.180
Why?
Lymphoma, B-Cell
1
2021
62
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Sequence Analysis, DNA
2
2018
230
0.170
Why?
Cell Cycle
1
2021
240
0.170
Why?
Cell Cycle Proteins
1
2021
170
0.170
Why?
B-Lymphocytes
1
2021
180
0.170
Why?
Lymphoma, Follicular
1
2020
27
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Leukemia, Plasma Cell
1
2020
33
0.160
Why?
Cell Line, Tumor
4
2024
1436
0.160
Why?
Female
13
2025
28262
0.160
Why?
Aged
10
2025
10191
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Genes, myc
1
2019
39
0.150
Why?
Middle Aged
10
2025
13096
0.150
Why?
Aged, 80 and over
6
2025
3420
0.150
Why?
Tumor Suppressor Protein p53
2
2017
224
0.150
Why?
Mutagenesis
1
2018
60
0.140
Why?
Transplantation, Autologous
4
2024
488
0.140
Why?
Genome
1
2018
62
0.140
Why?
Homologous Recombination
1
2018
41
0.140
Why?
Male
13
2025
26863
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Flow Cytometry
1
2018
400
0.130
Why?
Survival Rate
4
2021
952
0.130
Why?
Animals
8
2024
13507
0.130
Why?
DNA Repair
1
2018
196
0.130
Why?
DNA Copy Number Variations
3
2022
117
0.120
Why?
Adult
8
2025
14170
0.120
Why?
Remission Induction
3
2021
219
0.120
Why?
Genes, Neoplasm
1
2015
31
0.120
Why?
Pattern Recognition, Automated
1
2015
40
0.120
Why?
Cluster Analysis
1
2015
233
0.110
Why?
Follow-Up Studies
4
2021
2291
0.110
Why?
Databases, Protein
1
2013
28
0.100
Why?
Protein Structure, Secondary
1
2013
71
0.100
Why?
Sequence Alignment
1
2013
121
0.100
Why?
Amino Acid Sequence
1
2013
574
0.090
Why?
Chromatin
2
2023
141
0.090
Why?
T-Lymphocytes
2
2024
329
0.090
Why?
Breast Neoplasms
1
2020
1205
0.090
Why?
Adenocarcinoma
1
2015
404
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
263
0.080
Why?
Tumor Burden
2
2020
136
0.080
Why?
Alleles
2
2021
278
0.080
Why?
Clone Cells
2
2021
76
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
69
0.080
Why?
Histones
2
2021
316
0.080
Why?
DNA, Neoplasm
2
2020
146
0.080
Why?
Lung Neoplasms
1
2015
634
0.070
Why?
DNA Mutational Analysis
2
2020
180
0.070
Why?
Treatment Outcome
4
2020
5486
0.070
Why?
DNA Methylation
2
2023
592
0.070
Why?
Recurrence
2
2021
683
0.070
Why?
Genomic Instability
2
2018
89
0.070
Why?
Risk Factors
3
2021
3952
0.060
Why?
Cell Proliferation
2
2021
1029
0.060
Why?
ROC Curve
1
2025
254
0.060
Why?
Internet
2
2018
262
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
115
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Xenograft Model Antitumor Assays
1
2024
222
0.050
Why?
Antibodies
1
2024
150
0.050
Why?
Proteasome Inhibitors
1
2024
105
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Integrins
1
2023
31
0.050
Why?
Oxidative Phosphorylation
1
2023
46
0.050
Why?
Cytogenetic Analysis
1
2023
80
0.050
Why?
B-Cell Maturation Antigen
1
2024
98
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
19
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
96
0.050
Why?
Immunoglobulins
1
2023
76
0.050
Why?
Forkhead Transcription Factors
1
2023
121
0.050
Why?
Retrospective Studies
2
2025
6671
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Syndecan-1
1
2021
73
0.050
Why?
Spliceosomes
1
2021
10
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
RNA Splicing
1
2021
41
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Alternative Splicing
1
2021
61
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Phosphoproteins
1
2021
122
0.040
Why?
Ecosystem
1
2021
96
0.040
Why?
Single-Cell Analysis
1
2020
73
0.040
Why?
Mice, Transgenic
1
2021
564
0.040
Why?
Cell Differentiation
1
2022
673
0.040
Why?
DNA
1
2023
549
0.040
Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
Why?
Melphalan
1
2020
181
0.040
Why?
Neoplasm Invasiveness
1
2020
278
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Osteogenesis
1
2022
366
0.040
Why?
Multivariate Analysis
1
2021
602
0.040
Why?
Combined Modality Therapy
1
2021
639
0.040
Why?
Maintenance Chemotherapy
1
2019
51
0.040
Why?
Disease Models, Animal
1
2024
1486
0.040
Why?
Apoptosis
1
2024
1121
0.040
Why?
Cell Survival
1
2020
602
0.040
Why?
Promoter Regions, Genetic
1
2020
474
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.030
Why?
Reproducibility of Results
1
2021
1217
0.030
Why?
Genome-Wide Association Study
1
2018
187
0.030
Why?
Information Dissemination
1
2018
86
0.030
Why?
Fibroblast Growth Factors
1
2017
47
0.030
Why?
STAT3 Transcription Factor
1
2017
87
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1378
0.030
Why?
Prospective Studies
1
2023
2457
0.030
Why?
Thalidomide
1
2019
378
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Proportional Hazards Models
1
2018
444
0.030
Why?
Kaplan-Meier Estimate
1
2018
485
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Cohort Studies
1
2020
1553
0.030
Why?
Models, Genetic
1
2016
172
0.030
Why?
Antineoplastic Agents
1
2024
1221
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
150
0.030
Why?
Survival Analysis
1
2017
673
0.030
Why?
Stem Cell Transplantation
1
2016
187
0.030
Why?
Dogs
1
2015
183
0.030
Why?
Databases, Genetic
1
2015
83
0.030
Why?
Time Factors
1
2021
3000
0.030
Why?
Sequence Analysis, RNA
1
2015
99
0.030
Why?
Genetic Testing
1
2015
130
0.030
Why?
Longitudinal Studies
1
2016
747
0.030
Why?
Child
1
2023
7229
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description